aducanumab trials said thursday news conference held annual clinical trials alzheimer disease meeting san diego found results exhilarating know disease know means lose slice slice hang triumph cohen said citing statistic new data suggesting scores gaging disease progression trial participants highest doses declined 40 percent slowly taking placebo think disease long slow disease slow winning happy data convinced not cure not treatment going noticeable difference disease course says robert howard professor old age psychiatry university college london real important proof concept not clinically useful treatment based data lot riding trials aducanumab results upended research world drug truly works finding support